Intercept Pharmaceuticals reported $-20825000 in Net Income for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Acadia Pharmaceuticals ACAD:US USD -41725000 14.54M
Acorda Therapeutics ACOR:US USD 19.14M 33M
Alnylam Pharmaceuticals ALNY:US USD -207493000 198.43M
Amarin AMRN:US USD -5140000 64.82M
Amgen AMGN:US USD 1.62B 527M
Arrowhead Research ARWR:US USD -41325000 44.19M
AstraZeneca AZN:LN USD 901M 739M
Biogen BIIB:US USD 550.4M 584.3M
Bluebird Bio BLUE:US USD -76520000 23.62M
Bristol Myers Squibb BMY:US USD 2.02B 416M
Eli Lilly And LLY:US USD 1.94B 486M
Enanta Pharmaceuticals ENTA:US USD -28986000 2.64M
Esperion Therapeutics ESPR:US USD -55487000 370K
Galectin Therapeutics GALT:US USD -8597000 1.02M
Gilead Sciences GILD:US USD 1.64B 149M
GlaxoSmithKline GSK:LN GBP 1.5B 8.82B
Intercept Pharmaceuticals ICPT:US USD -20825000 288.28M
Moderna Inc MRNA:US USD 1.46B 422M
Neurocrine Biosciences NBIX:US USD 89M 20.5M
Novartis NOVN:VX USD 1.47B 107M
Ptc Therapeutics PTCT:US USD -170889000 61.57M
Regeneron Pharmaceuticals REGN:US USD 1.2B 118.6M
Sangamo Biosciences SGMO:US USD -51973000 1.18M
Sarepta Therapeutics SRPT:US USD -109244000 148.49M
Vertex Pharmaceuticals VRTX:US USD 818.9M 111.6M
YTE INCY:US USD 28.46M 84.31M